API 0.00% $1.53 australian pharmaceutical industries limited

keeping the ball in the air, page-5

  1. 2,000 Posts.
    lightbulb Created with Sketch. 27
    Some externalities as well: the Grexit will weight heavily on the market in the next week or so. Should be plenty of buying opportunities across the board. API will be one of them. Fundamentally a good company, but the SP got ahead of them.

    SAP is a worry also: I've never known ANY company that has chosen this system that hasn't had major issues. Usually way over time and over budget. It normally takes up to 3 years or so to truly bed down with advantages flowing thereafter. When are SAP going to be honest about start-up costs!? SAP by name, sap by nature.
 
watchlist Created with Sketch. Add API (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.